alzheimer's glp-1 Role of glucagon-like peptide-1 receptor agonists in disease and Parkinson's disease | Journal of Biomedical Science GLP-1 Drugs May Help Prevent

This is inspired by pharmaceutical delivery technology, transferring pharma-quality methods to nutraceuticals

Ingredients winian L-carnitine 733.5 mg of which: L-carnitine 500 mg L-ornithine 50 mg L-arginine 30 mg Chromium 50 g (125%*) *NRV - nutrient reference value

Although strict glycemic control has beneficial effects on microvascular complications (retinopathy, nephropathy or neuropathy), it does not seem to reduce the risk of cardiovascular disease, and it is associated with an increased risk of hypoglycemia in patients with DM2.3,6 Until recently, the antihyperglycemic drugs available have improved glycemic control, but without much benefits on cardiovascular and/or renal risk

Following oral administration, 10% is recovered in urine